Taiko Pharmaceutical Co., Ltd. engages in the manufacture and sale of general medications particularly non-prescription gastrointestinal drugs and designated quasi drugs. It operates through the following segments: Pharmaceuticals, Infection Control, and Others. The Pharmaceuticals segment handles the sale of gastrointestinal drugs such as Seirogan, Seirogan Toui A, and Seirogan Quick C. The Infection Control segment offers hygiene products such as Cleverin and clev&and. The Others segment provides vinegar-related products. The company was founded by Otojiro Shibata in July 1940 and is headquartered in Osaka, Japan.

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

Vibrant has developed a prescribed, non-drug digital treatment platform for GI disorders, delivering stimulation to the colon, focusing on its first indication Chronic Idiopathic Constipation (CIC). Its non-drug data-driven solution for CIC helps patients obtain relief and regain quality of life, empowers physicians with tools to provide optimized and better care, and motivates payors to adopt non-drug treatment options that lower health risks and potential comorbidities, alleviating financial burden on the healthcare system.

Sichuan Juhao Biotechnology Co., Ltd., established on 2015-10-10, The scope of business includes bioengineering technology research and experimental development and technology promotion services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Sichuan Xing Focus Pharmaceutical Technology Co., Ltd., established on 2016-08-26, Business scope includes medical research and experimental development.

Sichuan Yichuang Biotechnology Co., Ltd., established on 2016-08-19, Business scope includes biotechnology extension services;Bioengineering technology research and experimental development and technology promotion services.

Jiangsu Kaiwei Pharmaceutical Packaging Co., Ltd., established on 1994-01-26, Business scope includes pharmaceutical,food packaging material,Paper Tube,Paper box manufacturing;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).Packaging and decoration printing;Print binding service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Chengdu Fengmi Biotechnology Co., Ltd., established on 2016-05-18, The scope of business includes biotechnology research and development and promotion services(The above items subject to approval according to law,Business activities can only be carried out after approval by relevant departments).

Bayer HealthCare Ltd., established on 1995-08-25, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug import and export;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;food sales;Health food production;food production;Production of formula food for special medical purpose;Cosmetic production;Production of hygiene products and single-use medical products;Disinfectant production(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Cosmetics Wholesale;Cosmetics Retail;internet sales(Except for products that require a license for sale);Food import and export;software development;software sales;Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Manufacturing of computer software, hardware and peripheral equipment;Software outsourcing service;Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;Special Equipment Repair;Import and export;Technology Import and Export;Import and export agency;Sales of hygiene products and single-use medical products;Disinfectant sales(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Sales of daily chemical products.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Jiangxi Juwang Pharmaceutical Co., Ltd., a subsidiary of Jiangxi Yintao Pharmaceutical Co., Ltd., is a company headquartered in Fuzhou, China. The firm manufactures pharmaceutical products.

The First Hospital of Jilin University, a subsidiary of Jilin University, is a Chinese company located in Changchun. The firm owns and operates hospital.

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

McNeil-PPC, Inc. manufactures pharmaceutical and personal care products. The company was founded on December 30, 1988 and is headquartered in Fort Washington, PA.

Atomic Hi-Tech is a high-tech enterprise company that provides nuclear technology application products. The company covers radiopharmaceuticals, radiolabeled compounds, nuclear medicine services, radioactive sources, tracers, medical devices, and other fields. Atomic Hi-Tech was established in 2001 and is headquartered in Beijing, China.

Jiangsu Changjiang Pharmaceutical Co., Ltd., established on 2002-06-20, The scope of business includes large-volume injections,tablet,hard capsule,Granules,Psychotropic drug manufacturing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Production of Class III Medical Devices;Class III medical device business;Production of Class II Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Sales of Class II Medical Devices;Production of Class I Medical Devices;Sales of Class I Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Catering Services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Catering Management(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Toyo Capsule is a healthcare based agency that develops, manufactures & sells ethical drugs, dietary supplements & contract processing.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Anhui Yuebo Biopharmaceutical Co., Ltd., established on 1998-04-28, The business scope includes small volume injections(Contains anti-tumor),Freeze-dried powder injection(Contains antineoplastic drugs),powder injection(Contains cephalosporins),hard capsule,soft capsule,Granules,Chinese herbal medicine,tablet,oral suspension,Traditional Chinese Medicine Oral Liquid,vitaminsE,API[vitaminsE(natural type)]Production(Operate within the validity period of the license);Extraction of traditional Chinese medicine extract;New products of traditional Chinese medicine,New Technology,new technology research,to develop,Promotion and import and export business(Limited license scope).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Laiwu Zhaoyuan Machinery Equipment Co., Ltd., established on 2017-12-22, The business scope includes construction machinery and equipment,auto parts(except engine),Sales of electrical equipment;Ordinary mechanical parts processing and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tianjin Hankang Pharmaceutical Biotechnology Co., Ltd. is a high-tech enterprise with independent intellectual property rights and specialized in R&D, production and sales of pharmaceuticals. In 2009, he was awarded the title of “Tianjin Enterprise Technology Center”. In 2013, he was included in the list of small giant growth companies that the mayor focused on. In 2014, Hankang R&D Center was named “Tianjin Key Laboratory of Enterprises”. 　　Hankang is mainly engaged in the research of new chemical drugs, and the technical sources are all independent research and development. The company has a professional research team, technicians are all undergraduate or above, and at the same time employ many well-known domestic and foreign experts as technical consultants, scientific research results are remarkable. At present, more than 180 products have been successfully developed, more than 40 new drug certificates, more than 90 clinical approvals for new drugs, and more than 40 production approvals. He applied for more than 140 invention patents and obtained more than 60 invention patent certificates. He was awarded Tianjin Tianjin Invention Patent Pilot Enterprise twice.